Table 2 Clinical characteristics of the study group, n = 51

Clinical characteristics of the study group

Age at the genetic inquest (mean ± SD, years)

44.8 ± 13.8

Male sex (n, %)

35 (68.6)

AAD (n,  %)

17 (33.3)

Age at AAD (mean ± SD, years)

40.1 ± 13.0

Planned TAA surgery (n, %)

25 (49)

Age at planned TAA surgery (mean ± SD, years)

42.2 ± 17

Planned TAA surgery—first procedure in the patient (n, %)

19 (37.3)

Age at the planned TAA surgery- first procedure in the patient (mean ± SD, years)

44 ± 16.8

TAA with no criteria for surgery (n, %)

15 (29.4)

Age at last examination (mean ± SD, years)

39.9 ± 14.9

Suspected MFS (n, %)

13 (25.5)

Familial TAAD

25 (49)

Associated structural abnormalities (n, %)

BAV

11 (21.6)

CoA + BAV

1 (1.9)

ASD and LVNC

1 (1.9)

Other CV diseases (n, %)

Stroke

3 (5.8)

CAD

6 (11.7)

Peripheral artery aneurysms

3 (5.8)

Hypertension

33 (64.7)

Other diseases (n, %)

Mild-to-moderate intellectual disability

2 (3.9)

Rheumatid arthritis

1 (1.9)